Asztma: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• NLRP3 0
• IL-4 0
• MAPK 0
• PI3K 0
• TSLP 2
• STAT3 0
• AKT 0
• IL-13 0
• mTOR 0
• NRF2 0
• TNF 0
• TLR4 0
• GLP-1 0
• IL-17 0
• JAK 1
• PPAR 0
• HIF-1 0
• IL-6 0
• JNK 0
• AMPK 0
• ERK 0
• CD40 0
• COX-2 0
• HMGB1 0
• IL-1 1
• MMP-9 0
• STING 0
• EGFR 0
• SIRT1 0
• TP53 0
• YAP 0
• CTNNB1 0
• GPX4 0
• METTL3 0
• PD-1 0
• PDE4 0
• PTEN 0
• VEGF 0
• CCR5 0
• CFTR 0
• PD-L1 0
• PKM2 0
• ALK 1
• BDNF 0
• CD19 0
• CD38 0
• CXCR4 0
• FGFR 0
• FTO 0
• GIP 0
• HDAC 0
• IGF1R 0
• IL-23 0
• KIT 0
• MYC 0
• PCSK9 0
• SGLT2 0
• STK11 0
• ACE2 0
• APOE 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NHLBI · F32

  Molecular mechanisms of acquired ciliary dysfunction in chronic inflammatory airway disease

  University of Colorado Denver· Aurora, Egyesült Államok· 76 300 USD awarded in fiscal year 2026· until 2029. szept.

• NIH NIAMS · F32

  Understanding the role of innate lymphoid cells within psoriasis relapse

  Ohio State University· Columbus, Egyesült Államok· 84 580 USD awarded in fiscal year 2026· until 2027. szept.

• NIH NHLBI · R01

  Discovery of exposome-associated asthma genetic variants and endotypes based on enhancer architecture

  University of Kentucky· Lexington, Egyesült Államok· 1 462 058 USD awarded in fiscal year 2026· until 2028. júl.

• NIH NHLBI · R01

  Shortening the Diagnostic Odyssey for Children with Rare Pulmonary Diseases (RPD)

  Boston Children's Hospital· Boston, Egyesült Államok· 2 650 223 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NHLBI · R43

  Developing a novel, non-invasive wearable device for COPD diagnosis andMonitoring

  Samay, Inc.· Mountain View, Egyesült Államok· 469 388 USD awarded in fiscal year 2026· until 2027. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  Targeting airway lymphocytes in asthma and biologics treatment (TARGET-AIR-LAB)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 999 008 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-CSA

  Socio-environmental nexus for sustainable health outcomes in pediatric asthma: a twinning initiative (SENSO-TWIN)

  Panepistimio Patron· Rio Patras, Görögország· EU contribution 1 499 870 EUR· until 2029. dec.· 5 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  A doctoral training programme for next-generation LUNG-targeted non-viral GENEtic MEDicines (LUNG-GENEMED)

  Politecnico di Milano· Milano, Olaszország· EU contribution 3 876 613 EUR· until 2030. nov.· 7 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Revealing the neuroimmune communication for better treatment outcomes in food allergy (AllergyREBELL)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 252 180 EUR· until 2028. okt.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation (semiQ2)

  Agencia Estatal Consejo Superior de Investigaciones Cientificas· Madrid, Spanyolország· EU contribution 209 915 EUR· until 2028. szept.

  The disease is named only in the funder's project summary, not in the title.

10 of 931 running projects, newest first. Listed amounts together: 602,1 M USD + 58,2 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)

  NCT07600190· University of North Carolina, Chapel Hill· Forrás

• Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents

  NCT04748055· University of North Carolina, Chapel Hill· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 18
• Organoids 2
• Mendelian Randomization Analysis 81
• Gene Expression Profiling 73
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 1
• Exome Sequencing 2
• Proteomics 26
• Metabolomics 47
• Mass Spectrometry 16
• Flow Cytometry 18
• Immunohistochemistry 12
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 12
• Machine Learning 69
• Deep Learning 10
• Cohort Studies 249
• Genome-Wide Association Study 100

• Cell-Type Deconvolution of Equine BALF RNA-Seq: A Critical Comparison with Matched Single-Cell Data.

  Genes (Basel), 2026. jún.

• Single-cell RNA sequencing unraveled immune-related expression heterogeneity and lymphoid cell development dysregulation in childhood asthma.

  Front Immunol, 2026. jan.

• scRNA-sequencing Reveals Bu-Shen-Yi-Qi formula (BSYQF) ameliorates airway remodeling via regulating imbalanced M1/M2 macrophage subtypes in chronic asthmatic mice.

  J Ethnopharmacol, 2025. nov.

• Single-Cell RNA Sequencing Identifies a Unique Macrophage Population in a Mouse Model of Ozone-induced Asthma Exacerbation.

  Am J Respir Cell Mol Biol, 2025. okt.

• Fasting-induced FOXO4 blunts human CD4+ T helper cell responsiveness.

  Nat Metab, 2021. márc.

• Epigenome-wide effects of vitamin D on asthma bronchial epithelial cells.

  Epigenetics, 2019. jún.

• Factors influencing the infant gut microbiome at age 3-6 months: Findings from the ethnically diverse Vitamin D Antenatal Asthma Reduction Trial (VDAART).

  J Allergy Clin Immunol, 2016. okt.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.